During the past decade, Miami Valley Hospital South conducted 146 clinical trials. In the 10-year time frame, 146 clinical trials started and 47 clinical trials were completed, i.e. on average, 32.2% percent of trials that started reached the finish line to date. In the past 5 years, 69 clinical trials started and 45 clinical trials were completed. i.e. 65.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Miami Valley Hospital South" #1 sponsor was "National Cancer Institute (NCI)" with 84 trials, followed by "SWOG Cancer Research Network" with 30 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "NRG Oncology" with 17 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Miami Valley Hospital South" #1 collaborator was "National Cancer Institute (NCI)" with 84 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Miami Valley Hospital South" are "Stage IV Lung Cancer AJCC v8" (8 trials), "Invasive Breast Carcinoma" (7 trials), "Recurrent Lung Non-Small Cell Carcinoma" (7 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials) and "Recurrent Breast Carcinoma" (6 trials). Many other conditions were trialed in "Miami Valley Hospital South" in a lesser frequency.

Most popular intervention types in "Miami Valley Hospital South" are "Drug" (143 trials), "Other" (100 trials), "Biological" (71 trials), "Procedure" (54 trials) and "Radiation" (20 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (43 trials), "Laboratory Biomarker Analysis" (41 trials), "Computed Tomography" (34 trials), "Biospecimen Collection" (28 trials) and "Questionnaire Administration" (27 trials). Other intervention names were less common.

The vast majority of trials in "Miami Valley Hospital South" are 136 trials for "All" genders, 28 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Miami Valley Hospital South". undefined are not yet recruiting, 64 are recruiting, 78 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Miami Valley Hospital South, 3 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Miami Valley Hospital South, 4 "Phase 1" clinical trials were conducted, 92 "Phase 2" clinical trials and 85 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".